ClinicalTrials.Veeva

Menu

Psychometric Validation of the Hemophilia Functional Ability Scoring Tool (Hemo-FAST)

Sobi logo

Sobi

Status

Completed

Conditions

Hemophilia B
Hemophilia A

Treatments

Diagnostic Test: Hemophilia Joint Health Score (HJHS)

Study type

Observational

Funder types

Industry
Other

Identifiers

NCT04731701
Sobi.HAEM89-005

Details and patient eligibility

About

The purpose of this study is to validate the newly developed Hemophilia Functional Ability Scoring Tool (Hemo-FAST), which is a fast and simple scoring in haemophilia able to assess patient-reported functional mobility.

Full description

The purpose of this study is to validate the newly developed Hemophilia Functional Ability Scoring Tool (Hemo-FAST), which is a fast and simple scoring in haemophilia able to assess patient-reported functional mobility for adult haemophilia patients.

Enrollment

180 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion and exclusion criteria

Inclusion Criteria:A patient must fulfil the following criteria in order to be included in the study:

  1. Age ≥18 years.
  2. Diagnosis of haemophilia A or B.
  3. Capable of completing the study Patient-Reported Outcome (PRO) questionnaires in French.
  4. Signed informed consent.

Exclusion Criteria:

The presence of any of the following criteria will exclude a patient from inclusion in the study:

  1. Joint replacement within last 6 months.
  2. Patients with a non-resolved joint or muscle bleeding event at the enrolment visit or ≤ 7 days prior to the enrolment visit.
  3. Patients with comorbid illnesses such as juvenile arthritis, muscular dystrophy, neurologic illness/cognitive impairment, or other illnesses that may independently affect HJHS and Hemo-FAST scores and/or limit the ability of the patient to participate in the study as determined by the investigator.

Trial contacts and locations

16

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2025 Veeva Systems